Diabetes Mellitus, Type 2: all 9,590 studies
Page 77 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)CompletedNCT01541956Phase 4
- Special Survey for Patients With Type 1 or Type 2 DiabetesCompletedNCT01538589
- Paediatric Subjects - Special SurveyCompletedNCT01538576
- Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy VolunteersCompletedNCT01538511Phase 1
- Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic PatientsCompletedNCT01538290
- A Study To Evaluate The Effects Of PF-05175157 In Healthy VolunteersCompletedNCT01537497Phase 1
- Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?CompletedNCT01536808Not applicable
- Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 DiabetesCompletedNCT01536652
- Physiological Concept of Insulin Therapy in Subjects With Type 2 DiabetesCompletedNCT01536639
- Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the NetherlandsCompletedNCT01536626
- Post Marketing Surveillance Study of Biphasic Insulin Aspart 30CompletedNCT01536613
- Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 DiabetesCompletedNCT01536600
- To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered SeparatelyCompletedNCT01535677Phase 1
- Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes MellitusCompletedNCT01535612Not applicable
- Efficacy and Safety of DLBS3233 in Prediabetic PatientsCompletedNCT01531933Phase 3
- Single Oral Dose of BeneFlax to Healthy Young and Older AdultsCompletedNCT01531569Phase 2
- Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin AloneCompletedNCT01529541Phase 3
- A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus PatientsCompletedNCT01529528Phase 3
- Efficacy Study of the DIAMOND System to Treat Type 2 Diabetes MellitusCompletedNCT01529216Not applicable
- Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II DiabetesStatus unknownNCT01528059Phase 2/3
- Effects of DPP-4 Inhibition on TriglyceridesSuspendedNCT01527747Phase 4
- Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese SubjectsCompletedNCT01527630Phase 1
- Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 DiabetesCompletedNCT01527539Phase 3
- Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 DiabetesCompletedNCT01526980Phase 2
- The Verona Newly Diagnosed Type 2 Diabetes StudyStatus unknownNCT01526720
- A Community Pharmacy-based Program to Improve Management of DiabetesCompletedNCT01525992Not applicable
- Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in ChinaStatus unknownNCT01525693
- A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DMCompletedNCT01523405
- A Study Of Three PF-05190457 Formulations In Healthy VolunteersCompletedNCT01522807Phase 1
- A Randomized Cross-over Trial of the Postprandial Effects of Three Different Diets in Patients With Type 2 DiabetesCompletedNCT01522157Not applicable
- Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes PatientsCompletedNCT01521624Not applicable
- Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With DiabetesCompletedNCT01520818Phase 3
- Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 DiabetesCompletedNCT01520753Phase 3
- Diabetes in Europe - Prevention Using Lifestyle, Physical Activity and Nutritional Intervention in CataloniaStatus unknownNCT01519505Not applicable
- Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both MedicationsCompletedNCT01518101Phase 4
- Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 DiabetesCompletedNCT01517555Phase 1
- MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 DiabetesCompletedNCT01517321Phase 3
- Study of RO6807952 in Patients With Diabetes Mellitus Type 2TerminatedNCT01516476Phase 2
- Mechanisms of Diabetes Relapse After Bariatric SurgeryCompletedNCT01516320Not applicable
- Effect of Liraglutide on Heart Frequency in Healthy VolunteersCompletedNCT01516255Phase 1
- Evaluation of Safety and Parameters of Application TechniqueCompletedNCT01516242
- Safety and Tolerability of Liraglutide in Healthy Japanese Male VolunteersCompletedNCT01515592Phase 1
- A Trial of 18F-AV-133 Positron Emission Tomography (PET)TerminatedNCT01515384Phase 1
- Japanese Phase 1 Multiple Ascending Dose StudyCompletedNCT01515202Phase 1
- A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusTerminatedNCT01514838Phase 3
- Diet and Exercise in Type 2 Diabetes - a Randomized Controlled TrialCompletedNCT01513798Not applicable
- Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron DeficiencyCompletedNCT01513369Phase 3
- Personalized Glucose Predictive and Therapy Advisory System - DIAdvisor 2CompletedNCT01512654Not applicable
- A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 DiabetesCompletedNCT01511900Phase 1
- Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 DiabetesCompletedNCT01511692Phase 1
- Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic AgentCompletedNCT01511198Phase 2
- Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control GroupCompletedNCT01511185Phase 1
- Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 DiabetesCompletedNCT01511172Phase 2
- Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin TabletsWithdrawnNCT01510522Phase 4
- Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)CompletedNCT01510093Phase 2
- Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 DiabetesCompletedNCT01509755Phase 2
- Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 DiabetesCompletedNCT01509742Phase 1
- Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes MellitusCompletedNCT01509001Phase 4
- Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 DiabetesCompletedNCT01508949Phase 2
- Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 DiabetesCompletedNCT01508923Phase 2
- Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal WomenCompletedNCT01508858Phase 1
- Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney FunctionCompletedNCT01508806Phase 1
- Vitamin D Inadequacy is Associated With Incidence of Type 2 DiabetesCompletedNCT01508481
- Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver FunctionCompletedNCT01507389Phase 1
- Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 DiabetesCompletedNCT01507311Phase 1
- Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 DiabetesCompletedNCT01507285Phase 1
- Diabetes Attitudes Wishes and NeedsCompletedNCT01507116
- The Effect of a Nutritional Supplement in Individuals With Type 2 Diabetes Mellitus: a Pilot StudyCompletedNCT01505803Phase 1
- A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes PatientsCompletedNCT01505426Phase 3
- Predicting Response to Incretin Based Agents in Type 2 DiabetesCompletedNCT01503112
- Proteus Sustained Behavior Change StudyWithdrawnNCT01503008Not applicable
- Smoking Cessation Intervention for Diabetic PatientsCompletedNCT01501877Not applicable
- Establishing Cardiovascular Biomarkers to Define Preferred Lantus® UseStatus unknownNCT01500850Phase 4
- A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 DiabetesTerminatedNCT01500798Phase 1
- Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 DiabetesCompletedNCT01499108Phase 4
- Observational Study of NovoNorm® in Subjects With DiabetesCompletedNCT01498913
- An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical PracticeCompletedNCT01498900
- Life-long Tele-monitoring of Patients With Type 2 Diabetes Mellitus in Central GreeceCompletedNCT01498367Not applicable
- Pharmacokinetics of Insulin Detemir in Subjects With Type 2 DiabetesCompletedNCT01497600Phase 1
- Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 DiabetesCompletedNCT01497561Phase 1
- Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 DiabetesCompletedNCT01497522Phase 3
- Efficacy Study of Diabetes Group VisitsCompletedNCT01497301Not applicable
- Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2CompletedNCT01497132Phase 4
- A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes MellitusCompletedNCT01495013Phase 3
- Development of a Fast Measurement Technique of Insulin Resistance in HumanCompletedNCT01493934Phase 1/2
- Observational Study With InnoLet® in Daily Clinical PracticeCompletedNCT01492959
- Single Ascending Dose Trial in Patients With Type 2 DiabetesTerminatedNCT01492465Phase 1
- Observational Study With Mixtard® 30 NovoLet® to Assess Patient SatisfactionCompletedNCT01492218
- NovoLet® Acceptance Study Within the Hospital Practise in IndonesiaCompletedNCT01492205
- Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical PracticeCompletedNCT01492166
- NovoLet® Surveillance Study on Using Human Insulin System in IndonesiaCompletedNCT01492153
- Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy VolunteersCompletedNCT01490658Phase 1
- Surveillance Study of NovoRapid® for New Drug Re-examinationCompletedNCT01490112
- Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy VolunteersCompletedNCT01489644Phase 1
- Vitamin D Inadequacy on Postprandial Glucose in Type 2 Diabetes MellitusStatus unknownNCT01488916
- Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01487798Phase 4
- An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at BedtimeCompletedNCT01487421
- Special Survey for Type 1 or Type 2 Diabetic PatientsCompletedNCT01487408
- Special Survey for Paediatric SubjectsCompletedNCT01487382
- Special Survey of Production of Insulin Aspart Specific AntibodyCompletedNCT01487369